Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a systemic vasculitis as the main pathological changes of acute fever, rash diseases. Mainly occurred in children, 2-year-old with the highest incidence in children, 10-year-old children after the onset rarely.
Mucocutaneous lymph node syndrome is characterized by early onset that is manifested as fever, but also for the high fever, body temperature of 39 ℃ or more often, and sustained high fever for more than five days, antibiotic treatment is invalid. In the course of high fever, can occur in children with conjunctival hyperemia ball eyes (red eyes), chapped lips, tongue, nipple and congestive processes, like Yangmei. At the same time, the trunk may be erythema multiforme, skin rash similar to scarlet fever. In the acute stage, there will be a solid hand, foot swelling, sustained about a week, in the end means the toe nails along with the emergence of film at the junction of skin peeling. There are swollen neck lymph nodes.
A considerable number of children in the early signs of myocarditis and pericarditis, and some can be seen in children with heart expanded, or visible coronary artery involvement. Associated with coronary artery involvement, myocarditis or pericarditis in children with a high fatality rate.
Mucocutaneous lymph node syndrome of children, in the acute phase should be given high-dose aspirin treatment, in the febrile period of the daily dose per kilogram of body weight should be 50-100mg, the thermal back-dose can be halved, and then gradually reduce the volume, continuous application of 2 to 6 months. Aspirin can inhibit platelet aggregation, thereby preventing coronary artery thrombosis and obstruction.
Chinese medicine treatment of this disease have very good results. In the fever period, Chinese medicine should be the main heat-clearing and detoxifying treatment, and in line with the application of drug huoxuehuayu. In the recovery period, Chinese medicine should focus on Qingre Ziyin.
Friday, July 24, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment